Dupilumab bei CRSwNP, Asthma und atopischer Dermatitis: weniger Polypen und Exazerbationen

This is a preview of subscription content, access via your institution.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Dr. rer. nat. Miriam Sonnet.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sonnet, M. Dupilumab bei CRSwNP, Asthma und atopischer Dermatitis: weniger Polypen und Exazerbationen. Allergo J 29, 55–57 (2020). https://doi.org/10.1007/s15007-020-2662-7

Download citation